Description
Liver transplant anesthesia presents unique challenges that require meticulous planning, rapid decision-making, and constant physiological vigilance. This webinar focuses on the “7 Lows” encountered during liver transplantation—including hypotension, hypothermia, hypocalcemia, hypoglycemia, hypoxemia, low urine output, and low coagulation reserve—and their clinical implications. Participants will gain practical insights into early recognition, monitoring strategies, and evidence-based interventions to manage these critical scenarios effectively. The session will emphasize intraoperative hemodynamic control, metabolic management, and coordination with the transplant team. Designed for anesthesiologists and critical care professionals, this webinar offers actionable strategies to enhance patient safety and outcomes during liver transplantation.
Summary Listen
- **Anesthetic Requirements in Liver Transplantation:**
- The goal is to minimize anesthetic depth during liver transplantation. Excessive depth can negatively impact postoperative outcomes, especially in living donor liver transplantation (LDLT). Studies suggest patients with lower Model for End-Stage Liver Disease (MELD) scores require higher anesthetic depths. Frontal electroencephalogram (EEG) monitoring can reduce anesthetic use (MAC) without increasing postoperative delirium or awareness.
- **Central Venous Pressure (CVP) Management:**
- Maintaining low central venous pressure (CVP) during liver transplantation is traditionally emphasized. However, the benefit must outweigh the risks. While low CVP is associated with reduced blood loss, it can also impair graft perfusion. Monitoring CVP remains controversial, and there's no clear quantification of optimal CVP targets.
- **Systemic Vascular Resistance (SVR) and Hypotension:**
- Low systemic vascular resistance (SVR) and hypotension are common during liver transplantation, often due to increased nitric oxide production. Management involves vasopressors, potentially hydrocortisone, and vitamin C, although evidence supporting vitamin C's efficacy is limited. The emphasis remains on addressing underlying causes and optimizing hemodynamic stability.
- **Transfusion Thresholds and Blood Management:**
- Restricted transfusion thresholds are now standard practice in liver transplantation to minimize blood product exposure. Historically, high blood loss was common, but contemporary techniques and protocols have significantly reduced this. Current guidelines recommend transfusing red blood cells based on clinical signs of inadequate oxygen delivery.
- **Sodium Management (Hypernatremia and Hyponatremia):**
- Sodium concentrations must be managed carefully to prevent central pontine myelinolysis. Both hypernatremia and hyponatremia can occur, requiring diligent monitoring and appropriate correction rates. Hypernatremia is associated with poor outcomes in both pre- and post-transplant periods.
- **Potassium Management (Hyperkalemia and Hypokalemia):**
- Post-reperfusion hyperkalemia is a concern during liver transplantation. Factors like donor graft quality, degree of ischemia, and prior serum potassium levels influence the risk. Continuous potassium monitoring and prompt correction are essential.
- **Glucose Management (Hyperglycemia and Hypoglycemia):**
- Maintaining stable glucose levels is vital in liver transplantation. Both hyperglycemia and hypoglycemia should be avoided, aiming for a glucose level within a defined range. Glucose variability can increase oxidative stress. Newer studies indicate that the range should be narrow with an intensive treatment between 7.8 and 10 Million Units, to improve outcomes, but avoid low glycemia.
Sample Certificate
About the Speakers
Dr. Ashish Malik
Senior Consultant, Liver Transplant Anesthesia, Apollo Hospitals, Delhi
Comments
Comments
You must be logged in to leave a comment.